| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Maplight Therapeutics, Inc. (MPLT) have been net buyers, picking up 8,382,946 shares worth roughly $97.3M on balance. In the past 30 days, 0 insiders bought and 6 sold.
Not all activity pointed one way: 6 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), MPLT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 25.31M | $287.99M | - | |
| 10% | 2.73M | - | - | |
| CEO | 1.20M | $9.66M | -73,691 | |
| CFO | 387.8K | $6.97M | - | |
| Dir | 358.2K | $6.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Kroeger Christopher A. | Chief Executive Officer | Sell | 73,691 | $8.08 | $595,423.28 | -5.8% | - | - | |
| Oct 15, 2026 | Lillie James Woodruff | Chief Scientific Officer | Sell | 11,513 | $8.08 | $93,025.04 | -5.5% | - | - | |
| Oct 15, 2026 | Hanson Kristopher | General Counsel | Sell | 9,020 | $8.08 | $72,881.60 | -6.6% | - | - | |
| Oct 15, 2026 | Foff Erin Pennock | Chief Medical Officer | Sell | 15,355 | $8.08 | $124,068.40 | -4.9% | - | - | |
| Oct 15, 2026 | Kreitzer Anatol | Chief Discovery Officer | Sell | 12,248 | $7.84 | $96,024.32 | -6.8% | - | - | |
| Oct 15, 2026 | Gillis Jonathan | CAO And Interim CFO | Sell | 10,167 | $8.08 | $82,149.36 | -6.7% | - | - | |
| Sep 16, 2026 | Hanson Kristopher | General Counsel | Sell | 16,509 | $11.67 | $192,660.03 | -10.8% | - | - | |
| Aug 14, 2026 | Catalyst4, Inc. | 10% Owner | Buy | 4,400,000 | $11.38 | $50,072,000.00 | +21.0% | - | - | |
| Aug 3, 2026 | Lillie James Woodruff | Chief Scientific Officer | Sell | 22,082 | $12.54 | $276,908.28 | -9.8% | - | - | |
| Jul 30, 2026 | Catalyst4, Inc. | 10% Owner | Buy | 1,209,225 | $12.66 | $15,314,793.77 | +6.1% | - | - |